JP2011219478A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2011219478A5 JP2011219478A5 JP2011104172A JP2011104172A JP2011219478A5 JP 2011219478 A5 JP2011219478 A5 JP 2011219478A5 JP 2011104172 A JP2011104172 A JP 2011104172A JP 2011104172 A JP2011104172 A JP 2011104172A JP 2011219478 A5 JP2011219478 A5 JP 2011219478A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- amino acid
- acid sequence
- cdr1
- cdr3
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2011104172A JP2011219478A (ja) | 2009-03-19 | 2011-05-09 | 関節リウマチ治療剤 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2009067358 | 2009-03-19 | ||
| JP2009067358 | 2009-03-19 | ||
| JP2011104172A JP2011219478A (ja) | 2009-03-19 | 2011-05-09 | 関節リウマチ治療剤 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010511837A Division JP4809930B2 (ja) | 2009-03-19 | 2010-03-19 | 関節リウマチ治療剤 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2011219478A JP2011219478A (ja) | 2011-11-04 |
| JP2011219478A5 true JP2011219478A5 (https=) | 2013-05-02 |
Family
ID=42739764
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010511837A Active JP4809930B2 (ja) | 2009-03-19 | 2010-03-19 | 関節リウマチ治療剤 |
| JP2011104172A Pending JP2011219478A (ja) | 2009-03-19 | 2011-05-09 | 関節リウマチ治療剤 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010511837A Active JP4809930B2 (ja) | 2009-03-19 | 2010-03-19 | 関節リウマチ治療剤 |
Country Status (5)
| Country | Link |
|---|---|
| JP (2) | JP4809930B2 (https=) |
| KR (1) | KR101314880B1 (https=) |
| RU (1) | RU2524152C2 (https=) |
| TW (1) | TWI457134B (https=) |
| WO (1) | WO2010107108A1 (https=) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104761637B (zh) | 2006-03-31 | 2021-10-15 | 中外制药株式会社 | 调控抗体血液动力学的方法 |
| TWI438208B (zh) | 2007-01-23 | 2014-05-21 | 中外製藥股份有限公司 | 抑制慢性排斥反應之藥劑 |
| CA2728243C (en) | 2008-06-05 | 2020-03-10 | Chugai Seiyaku Kabushiki Kaisha | Il-6 inhibitor for suppressing neuroinvasion in pancreatic cancer |
| TWI440469B (zh) | 2008-09-26 | 2014-06-11 | Chugai Pharmaceutical Co Ltd | Improved antibody molecules |
| WO2011149051A1 (ja) | 2010-05-28 | 2011-12-01 | 中外製薬株式会社 | 抗腫瘍t細胞応答増強剤 |
| US10782290B2 (en) | 2013-06-11 | 2020-09-22 | National Center Of Neurology And Psychiatry | Method for predicting post-therapy prognosis of relapsing-remitting multiple sclerosis (RRMS) patient, and method for determining applicability of novel therapy |
| CA2972393A1 (en) | 2015-02-27 | 2016-09-01 | Chugai Seiyaku Kabushiki Kaisha | Composition for treating il-6-related diseases |
| US10697883B2 (en) | 2015-05-19 | 2020-06-30 | National Center Of Neurology And Psychiatry | Method for determining application of therapy to multiple sclerosis (MS) patient |
| WO2018203545A1 (ja) | 2017-05-02 | 2018-11-08 | 国立研究開発法人国立精神・神経医療研究センター | Ｉｌ－６及び好中球の関連する疾患の治療効果の予測及び判定方法 |
| JP7235249B2 (ja) | 2017-10-20 | 2023-03-08 | 学校法人兵庫医科大学 | 抗ｉｌ－６受容体抗体を含有する術後の癒着を抑制するための医薬組成物 |
| WO2019151418A1 (ja) | 2018-01-31 | 2019-08-08 | 元一 加藤 | Ｉｌ－６阻害剤を含有する喘息の治療剤 |
| US20220220210A1 (en) | 2019-03-29 | 2022-07-14 | Chugai Seiyaku Kabushiki Kaisha | Anti-il-6 receptor antibody-containing inhibitor for inhibiting deterioration of bbb function |
| EP3957324A4 (en) | 2019-04-17 | 2023-02-08 | Hiroshima University | THERAPEUTIC FOR UROLOGICAL ONCOLOGY CHARACTERIZED BY BEING ADMINISTRATED IN COMBINATION WITH IL-6 INHIBITOR AND CCR2 INHIBITOR |
| EP4159236A4 (en) | 2020-05-29 | 2024-08-21 | Chugai Seiyaku Kabushiki Kaisha | Antibody-containing formulation |
| IL305793A (en) | 2021-03-12 | 2023-11-01 | Hoffmann La Roche | A pharmaceutical preparation for the treatment or prevention of myasthenia gravis |
| WO2025198912A1 (en) | 2024-03-21 | 2025-09-25 | Hoffmann-La Roche Inc. | Methods of treating myasthenia gravis |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1306963C (zh) * | 1994-10-21 | 2007-03-28 | 岸本忠三 | 用于治疗il－6产生所致疾病的药物组合物 |
| PT1831258E (pt) * | 2004-12-28 | 2016-01-07 | Univ Genova | Anticorpos monoclonais contra nkg2a |
| WO2008020079A1 (en) * | 2006-08-18 | 2008-02-21 | Ablynx N.V. | Amino acid sequences directed against il-6r and polypeptides comprising the same for the treatment of deseases and disorders associated with il-6-mediated signalling |
| WO2009010539A2 (en) * | 2007-07-19 | 2009-01-22 | Ablynx. N.V. | Receptor for interleukin-6 (il-6) from macaca fascicularis |
| KR101680906B1 (ko) * | 2007-09-26 | 2016-11-30 | 추가이 세이야쿠 가부시키가이샤 | 항체 정상영역 개변체 |
| MX2010003329A (es) * | 2007-09-26 | 2010-04-27 | Chugai Pharmaceutical Co Ltd | Anticuerpo anti-receptor de il-6. |
| KR102057826B1 (ko) * | 2008-04-11 | 2019-12-20 | 추가이 세이야쿠 가부시키가이샤 | 복수 분자의 항원에 반복 결합하는 항원 결합 분자 |
| TWI440469B (zh) * | 2008-09-26 | 2014-06-11 | Chugai Pharmaceutical Co Ltd | Improved antibody molecules |
-
2010
- 2010-03-19 JP JP2010511837A patent/JP4809930B2/ja active Active
- 2010-03-19 WO PCT/JP2010/054763 patent/WO2010107108A1/ja not_active Ceased
- 2010-03-19 RU RU2011142183/10A patent/RU2524152C2/ru active
- 2010-03-19 KR KR1020117024354A patent/KR101314880B1/ko active Active
- 2010-03-19 TW TW099108133A patent/TWI457134B/zh active
-
2011
- 2011-05-09 JP JP2011104172A patent/JP2011219478A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2011219478A5 (https=) | ||
| JP2012136541A5 (https=) | ||
| JP2013517277A5 (https=) | ||
| RU2011142183A (ru) | Средство для лечения ревматоидного артрита | |
| JP2017176174A5 (https=) | ||
| JP2012507294A5 (https=) | ||
| JP2014205674A5 (https=) | ||
| JP2013539454A5 (https=) | ||
| PH12014500089A1 (en) | Antibodies that bind to ox40 and their uses | |
| WO2012006596A3 (en) | Anti-human respiratory syncytial virus (rsv) antibodies and methods of use | |
| HRP20211343T1 (hr) | Protutijela protiv dkk-1 | |
| CA2813849C (en) | Secukinumab for use in the treatment of ankylosing spondylitis | |
| HRP20192295T1 (hr) | Optimizirana monoklonska protutijela protiv inhibitora faktora tkivnog puta (tfpi) | |
| JP2008538564A5 (https=) | ||
| JP2015522252A5 (https=) | ||
| HRP20161740T1 (hr) | Ljudske molekule za vezanje koje su sposobne neutralizirati viruse influence a filogenetske skupine 1 i filogenetske skupine 2, te viruse influence b | |
| NZ709390A (en) | Folate receptor 1 antibodies and immunoconjugates and uses thereof | |
| RU2571204C3 (ru) | Специфические связывающие агенты против в7-н1 | |
| JP2015514110A5 (https=) | ||
| JP2018536393A5 (https=) | ||
| JP2011528902A5 (https=) | ||
| JP2014526898A5 (https=) | ||
| JP2012510461A5 (https=) | ||
| JP2007051159A5 (https=) | ||
| UA118441C2 (uk) | Антитіло, що розпізнає альфа-синуклеїн |